Business · 22/10/20261 min read
Granata Bio completes the screening in phase III GRACE study of GB-hMG
Summary
Pivotal IVF study advances into pregnancy follow-up, with the first GRACE baby expected by year end BOSTON, Oct. 22, 2026 — Granata Bio Corporation, a biopharmaceutical company dedicated to advancing rep...